PGNY Live signals | Maximize Profits with Getagraph.com

SELL 102872 min ago

@ $40.81

Issued: 14 Feb 2024 @ 09:30

Return: -20.36%

Previous signal: Feb 13 - 13:58

Previous signal: Buy

Return: 1.39 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	588 643
Average Volume	845 962
Market Cap	3.14B
EPS	$0 ( 2024-02-27 )
Next earnings date	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	52.42
ATR14	$0.0270 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Anevski Peter	Sell	7 977	Common Stock
2024-04-01	Schlanger David J	Sell	1 000	Stock Option (Right to Buy)
2024-04-01	Schlanger David J	Buy	1 000	Common Stock
2024-04-01	Schlanger David J	Sell	2 681	Common Stock
2024-04-01	Schlanger David J	Sell	1 000	Common Stock

INSIDER POWER
6.44
Last 100 transactions
Buy: 1 507 627 \| Sell: 1 384 727

Volume Correlation

Long: 0.34 (neutral)

Short: 0.13 (neutral)

Signal:(60.492) Neutral

Progyny Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Progyny Inc Correlation - Currency/Commodity

0.08
( neutral )

0.07
( neutral )

0.00
( neutral )

-0.01
( neutral )

0.34
( neutral )

0.13
( neutral )

Progyny Inc Financials

Annual	2023
Revenue:	$1.09B
Gross Profit:	$238.80M (21.94 %)
EPS:	$0.650

Q4	2023
Revenue:	$269.94M
Gross Profit:	$56.89M (21.08 %)
EPS:	$0.140

Q3	2023
Revenue:	$280.89M
Gross Profit:	$62.62M (22.29 %)
EPS:	$0.170

Q2	2023
Revenue:	$279.37M
Gross Profit:	$60.64M (21.71 %)
EPS:	$0.160

Financial Reports:

No articles found.

Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.